Hiroshi Yagasaki

Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor

Takahiro Ueda, Kohichiro Tsuji, Hiroshi Yoshino et al. · Journal of Clinical Investigation · 2000 · 282 citations · Full text

Life Sciences, Cell Biology, Hematology +16

First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy

Nao Yoshida, Ryōji Kobayashi, Hiromasa Yabe et al. · Haematologica · 2014 · 131 citations · Full text

Medicine, Hematology, Pediatrics +15

Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia

Hideki Muramatsu, Hideki Makishima, Anna Jankowska et al. · Blood · 2009 · 123 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Simultaneous Quantification of Epstein-Barr Virus, Cytomegalovirus, and Human Herpesvirus 6 DNA in Samples from Transplant Recipients by Multiplex Real-Time PCR Assay

Kaoru Wada, Naomi Kubota, Yoshinori Ito et al. · Journal of Clinical Microbiology · 2007 · 115 citations

Life Sciences, Infectious Diseases, Molecular Biology +13

Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia

Yoshiyuki Kosaka, Hiroshi Yagasaki, Kimihiko Sano et al. · Blood · 2007 · 111 citations

Medicine, Hematology, Pediatrics +16